Blue Bliss Aka Borax Molly Pellets (5-MAPB + 2-FMA + 5-MeO-MiPT)

PRODUCT DESCRIPTION

Introduction

Blue Bliss, also known as Borax Molly, is a combination research compound formulated into pentagonal sky blue pellets containing a blend of three distinct psychoactive research chemicals: 5-MAPB, 2-FMA, and 5-MeO-MiPT. This combination mimics the empathogenic and stimulant effects of MDMA but includes unique hallucinogenic properties due to the 5-MeO-MiPT component. Designed for research purposes, these pellets enable the study of complex psychoactive interactions and effects from mixed monoaminergic and serotonergic agents.

Chemical Composition and Dosages

• 5-MAPB (80 mg): A synthetic entactogen and empathogen acting as a serotonin-norepinephrine-dopamine releasing agent (SNDRA), responsible for mood enhancement and emotional connectivity.

• 2-FMA (20 mg): A potent stimulant, chemically related to methamphetamine, primarily acting as a norepinephrine-dopamine releasing agent (NDRA), contributing energy and wakefulness.

• 5-MeO-MiPT (2 mg): A serotonergic psychedelic with hallucinogenic properties acting as a non-selective serotonin receptor agonist, adding a psychedelic dimension to the blend.

Purity Level

Blue Bliss pellets are prepared with high-quality ingredients, ensuring a purity level above 95%. Each batch undergoes rigorous quality assurance to provide reliable materials for scientific research.

Physical Properties

• Appearance: Pentagonal sky blue solid pellets

• Purity: >95%, tested for quality assurance

• Packaging Options: Available in multiple quantities ranging from single units to bulk orders (1, 2, 5, 10, 25, 50, 100 units) to accommodate diverse research needs.

Pharmacological Profile and Mechanism of Action

The combined action of these compounds covers multiple neurotransmitter systems:

• 5-MAPB primarily promotes serotonin, dopamine, and norepinephrine release amplifying empathogenic effects.

• 2-FMA acts as a stimulant increasing alertness and energy by releasing norepinephrine and dopamine.

• 5-MeO-MiPT introduces psychedelic effects via serotonin receptor activation, especially 5-HT1 and 5-HT2 subtypes.

Together, this blend produces a complex profile that includes euphoric, empathogenic, stimulant, and mild psychedelic effects, allowing exploration of polypharmacology.

Research Applications

Blue Bliss pellets are ideal for studying the interaction of multiple monoaminergic agents and their combined neurochemical outcomes. The compound’s sophisticated profile also renders it useful for behavioral pharmacology, neurotoxicity assessments, and receptor pharmacodynamics research.

Safety and Handling Guidelines

• Use protective gloves, eye protection, and work in a ventilated lab environment.

• Avoid direct contact, inhalation, or ingestion outside supervised research conditions.

• Store in a cool, dry place sealed from moisture and light to preserve compound integrity.

• Handle dosing carefully to avoid unintended potent effects due to the combination nature.

Regulatory Status

As a combination of potent research chemicals, Blue Bliss pellets are subject to strict regulatory control in many jurisdictions. Researchers must verify and comply with all relevant laws governing procurement and use.

Frequently Asked Questions (FAQs)

1. What substances are contained in Blue Bliss pellets?
   5-MAPB (80mg), 2-FMA (20mg), and 5-MeO-MiPT (2mg).

2. What effects does this combination produce?
   Empathogenic, stimulant, and psychedelic effects mimicking MDMA-like experiences.

3. What purity level can be expected?
   Above 95% purity with quality assurance testing.

4. Are these pellets available in bulk?
   Yes, available in quantities from 1 to 100 units.

5. Is this blend legally controlled?
   Yes, subject to regulation due to constituent substances.

Conclusion

Blue Bliss Aka Borax Molly pellets offer a unique, high-purity combination of empathogenic, stimulant, and psychedelic research chemicals in a precisely dosed solid form. Their combined activity provides a valuable tool for complex neuropharmacological studies on multi-target psychoactive interactions under strict safety and regulatory compliance.